跳至主要内容
临床试验/EUCTR2011-005438-20-FI
EUCTR2011-005438-20-FI进行中(未招募)1 期

Effects of short-term atorvastatin treatment on prostate cancer - a pre-surgical pilot trial - Atorvastatin and prostate cancer

niversity of Tampere0 个研究点目标入组 160 人开始时间: 2012年5月4日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Histologically confirmed diagnosis of prostate adenocarcinoma
  • - Radical prostatectomy is chosen as prostate cancer treatment
  • - No prior cancer treatments of any kind
  • - The patient agrees to participate and signs an informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Any previous cancer treatment
  • - Usage of cholesterol-lowering medication, finasteride or dutasteride within a year from study inclusion
  • - Difficult renal or liver insufficiency
  • - Previous adverse effect during cholesterol-lowering treatment
  • - Usage of drugs or herbs during the study period that interact with atorvastatin (St John's Wort, HIV protease inhibitors, cyklosporin, macrolides, fusidic acid, phenytoin, carbamatsepin, dronedarone or oral antifungal drugs)

研究者

发起方
niversity of Tampere

相似试验

Reduction of prostate cancer growth with... | 临床试验